Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications
| Autor: | A. A. Tikhonov, Guzel Feyzkhanova, N. E. Kushlinskii, Olga Smoldovskaya, Alla Rubina |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Glycan Glycosylation Microarray Antibodies Neoplasm Clinical Biochemistry Computational biology Glycomics Structure-Activity Relationship 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Polysaccharides Neoplasms Biomarkers Tumor medicine Humans biology Biochemistry (medical) Cancer General Medicine Microarray Analysis medicine.disease carbohydrates (lipids) 030104 developmental biology chemistry 030220 oncology & carcinogenesis biology.protein Gene chip analysis Cancer biomarkers DNA microarray Protein Processing Post-Translational |
| Zdroj: | Clinical Chemistry and Laboratory Medicine (CCLM). 58:1611-1622 |
| ISSN: | 1437-4331 1434-6621 |
| DOI: | 10.1515/cclm-2019-1161 |
| Popis: | Glycosylation is one of the most common posttranslational modifications of proteins and lipids. In the case of tumors, cell transformation accompanied by aberrant glycosylation results in the expression of tumor-associated glycans that promote tumor invasion. As part of the innate immunity, anti-glycan antibodies recognize tumor-associated glycans, and these antibodies can be present in the bloodstream in the early stages of cancer. Recently, anti-glycan antibody profiles have been of interest in various cancer studies. Novel advantages in the field of analytical techniques have simplified the analysis of anti-glycan antibodies and made it easier to have more comprehensive knowledge about their functions. One of the robust approaches for studying anti-glycan antibodies engages in microarray technology. The analysis of glycan microarrays can provide more expanded information to simultaneously specify or suggest the role of antibodies to a wide variety of glycans in the progression of different diseases, therefore making it possible to identify new biomarkers for diagnosing cancer and/or the state of the disease. Thus, in this review, we discuss antibodies to various glycans, their application for diagnosing cancer and one of the most promising tools for the investigation of these molecules, microarrays. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|